Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Akihiko Suto"'
Autor:
Shohei Shikata, Takeshi Murata, Masayuki Yoshida, Hiromi Hashiguchi, Yukiko Yoshii, Ayumi Ogawa, Chikashi Watase, Sho Shiino, Hirokazu Sugino, Kenjiro Jimbo, Akiko Maeshima, Eriko Iwamoto, Shin Takayama, Akihiko Suto
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Adjuvant therapy for patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive, early breast cancer (EBC) remains challenging. The prognostic significance of HER2-low positivity in
Externí odkaz:
https://doaj.org/article/fb74a75d0068451ba262689765aa4798
Autor:
Haruhi Maseki, Kenjiro Jimbo, Chikashi Watase, Takeshi Murata, Sho Shiino, Shin Takayama, Nami Yamamoto, Kaishi Satomi, Akiko Maeshima, Masayuki Yoshida, Akihiko Suto
Publikováno v:
Asian Journal of Surgery, Vol 46, Iss 9, Pp 3700-3704 (2023)
Background/Objective: The occurrence of iatrogenic tumor cell seeding (seeding) in needle tract scars formed by core needle biopsy (CNB) or vacuum-assisted biopsy (VAB) is well known. Some risk factors for seeding have been reported, but the clinicop
Externí odkaz:
https://doaj.org/article/0c293de1f59a4974a726cfbfe97cc135
Autor:
Takeshi Murata, Chikashi Watase, Sho Shiino, Arisa Kurita, Ayumi Ogawa, Kenjiro Jimbo, Eriko Iwamoto, Masayuki Yoshida, Shin Takayama, Akihiko Suto
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Background There are currently no scoring-type predictive models using only easily available pre- and intraoperative data developed for assessment of the risk of advanced axillary lymph node metastasis (ALNM) in patients with breast cancer w
Externí odkaz:
https://doaj.org/article/655f5125b02645369f9b14f517b3cc7f
Autor:
Tomomi Sanomachi, Hitomi Sumiyoshi Okuma, Rui Kitadai, Asuka Kawachi, Shu Yazaki, Momoko Tokura, Motoko Arakaki, Ayumi Saito, Shosuke Kita, Kasumi Yamamoto, Aiko Maejima, Yuki Kojima, Tadaaki Nishikawa, Kazuki Sudo, Tatsunori Shimoi, Emi Noguchi, Yasuhiro Fujiwara, Hirokazu Sugino, Sho Shiino, Akihiko Suto, Masayuki Yoshida, Kan Yonemori
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionTriple-negative breast cancer (TNBC) is negative for hormone receptors and human epidermal growth factor receptor 2 (HER2). In stage I TNBC, adjuvant therapy or follow-up are performed according to risk factors, but clinical trial data is
Externí odkaz:
https://doaj.org/article/d1c7862b911d4555b6a5240fa9cffc46
Publikováno v:
Cells, Vol 12, Iss 18, p 2286 (2023)
Human epidermal growth factor receptor 2 (HER2) protein, which is characterized by the amplification of ERBB2, is a molecular target for HER2-overexpressing breast cancer. Many targeted HER2 strategies have been well developed thus far. Furthermore,
Externí odkaz:
https://doaj.org/article/664a6faab3da46868a8b6968d90799cd
Autor:
Ai Hironaka-Mitsuhashi, Shin Takayama, Kenjiro Jimbo, Akihiko Suto, Akihiko Shimomura, Takahiro Ochiya
Publikováno v:
Archives of Breast Cancer, Vol 9, Iss 1 (2022)
Background: Recurrence of breast cancer remains a critical problem. Therefore, it is imperative to identify biomarkers that accurately reflect disease state and develop novel drug therapies that are effective even after recurrence. MicroRNAs (miRNAs)
Externí odkaz:
https://doaj.org/article/d6063d6c41c04093b1da0848ec6ad7bd
Autor:
Chikashi Watase, Sho Shiino, Tatsunori Shimoi, Emi Noguchi, Tomoya Kaneda, Yusuke Yamamoto, Kan Yonemori, Shin Takayama, Akihiko Suto
Publikováno v:
Cancers, Vol 13, Iss 5, p 1078 (2021)
Breast cancer is the second most common origin of brain metastasis after lung cancer. Brain metastasis in breast cancer is commonly found in patients with advanced course disease and has a poor prognosis because the blood–brain barrier is thought t
Externí odkaz:
https://doaj.org/article/e35e41a03a6f4603bc0dd91ffa35adea
Publikováno v:
Journal of Clinical Medicine, Vol 8, Iss 9, p 1365 (2019)
In the era of precision medicine, targeted therapies have been implemented for various diseases. Genomic information guides decision-making in cancer treatment. The improvements in next-generation sequencing and polymerase chain reaction have made it
Externí odkaz:
https://doaj.org/article/d600833779e2467b92c875a6876ffe0d
Autor:
Takeshi Murata, Masayuki Yoshida, Sho Shiino, Ayumi Ogawa, Chikashi Watase, Kaishi Satomi, Kenjiro Jimbo, Akiko Maeshima, Eriko Iwamoto, Shin Takayama, Akihiko Suto
Publikováno v:
Breast Cancer Research and Treatment. 199:57-66
Purpose The impact of progesterone receptor (PR) status on the prognosis of breast cancer after isolated locoregional recurrence (ILRR) remains unclear. This study evaluated the impact of clinicopathologic factors, including PR status of ILRR, on dis
Autor:
Erina Odani, Tetsu Hayashida, masayuki kikuchi, Aiko Nagayama, tomoko seki, maiko takahashi, Akiko Matsumoto, Takeshi Murata, Rurina Watanuki, Takamichi Yokoe, Ayako Nakashoji, Hinako Maeda, Tatsuya Onishi, Sota Asaga, Takashi Hojo, Hiromitsu Jinno, Keiichi Sotome, Akira Matsui, Akihiko Suto, Shigeru Imoto, Yuko Kitagawa
Publikováno v:
Cancer Research. 83:P1-05
Although the categorization of ultrasound using the Breast Imaging Reporting and Data System (BI-RADS) has become widespread worldwide, the problem of inter-observer variability remains. To maintain uniformity in diagnostic accuracy, we have develope